Antiplatelet Therapy in a STEMI Patient with Gastroparesis

Supported by educational grants from Abbott, AstraZeneca, Bayer, Chiesi, NovoNordisk. This program is intended for healthcare providers.— cardio-met (@cardiomet_CE) June 1, 2021 3) The patient states that his abd pain has worsened and spread to his chest. He is...

The Use of P2Y12 Inhibitor Monotherapy After PCI

1) Welcome to a tweetorial on the use of P2Y12 inhibitor monotherapy after PCI! Accredited for 0.50 credits by @academiccme: physicians, nurses, pharmacists! I am @SVRaoMD. pic.twitter.com/RaLLuUZ7gB— cardio-met (@cardiomet_CE) April 20, 2021 3) 75 yo female...

De-escalation of P2Y12 Inhibitor Monotherapy PCI

1) Welcome to a tweetorial on de-escalation of P2Y12 inhibitor monotherapy after #PCI! Accredited for 0.50 credits by @academiccme: physicians, nurses, pharmacists! Expert faculty @drroxmehran— cardio-met (@cardiomet_CE) March 3, 2021 3) 69 yo M presenting with chest...

Management of a Challenging IWSTEMI

2) . . . Supported by Abbott, AstraZeneca, Bayer, Chiesi, NovoNordisk. Follow this thread for credit. And here is a case . . .— cardio-met (@cardiomet_CE) February 22, 2021 4) Other PMH: Crohn’s on chronic steroid therapy, budenoside & mesalamine; prostate...